The endocannabinoid system and amyloid-related diseases

被引：15
作者：
Ruiz-Valdepenas, Lourdes [1 ,2 ]
Benito, Cristina [1 ,2 ]
Maria Tolon, Rosa [1 ,2 ]
Martinez Orgado, Jose Antonio [3 ]
Romero, Julian [1 ,2 ]
机构：
[1] Hosp Univ Fdn Alcorcon, Lab Apoyo Invest, Alcorcon 28922, Spain
[2] Hosp Univ Fdn Alcorcon, CIBERNED, Alcorcon 28922, Spain
[3] Hosp Univ Puerta Hierro, Serv Pediat, Madrid 28222, Spain
来源：
EXPERIMENTAL NEUROLOGY | 2010年 / 224卷 / 01期
关键词：
CB2 CANNABINOID RECEPTOR; ALZHEIMERS-DISEASE; MICROGLIAL CELLS; IN-VITRO; DEFAULT NETWORK; LIPID RAFTS; MOUSE MODEL; FATTY-ACID; A-BETA; BRAIN;
D O I：
10.1016/j.expneurol.2010.03.024
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The endocannabinoid system may be the target of novel therapies in a wide variety of diseases. Among them, those related with amyloid accumulation will be discussed in the present review. Several components of this system (CB1 and CB2 receptors, endocannabinoids, FAAH enzyme) may participate in different aspects of amyloid pathophysiology such as, for instance, synaptic activity, cell migration, cytokine production or phagocytic activity. Consistent with recent data, putative lines of research and hypothesis will be discussed. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码：66 / 73
页数：8
相关论文
共 80 条
[1]  
ABUSH H, 2009, HIPPOCAMPUS IN PRESS, DOI DOI 10.1002/HIPO.20711
[2]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[3]  
Alger BE, 2002, PROG NEUROBIOL, V68, P247
[4]   Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells -: Implications for anandamide-induced apoptosis [J].
Bari, M ;
Battista, N ;
Fezza, F ;
Finazzi-Agrò, A ;
Maccarrone, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) :12212-12220
[5]   Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes [J].
Battista, Natalia ;
Bari, Monica ;
Tarditi, Alessia ;
Mariotti, Caterina ;
Bachoud-Levi, Anne-Catherine ;
Zuccato, Chiara ;
Finazzi-Agro, Alessandro ;
Genitrini, Silvia ;
Peschanski, Marc ;
Di Donato, Stefano ;
Cattaneo, Elena ;
Maccarrone, Mauro .
NEUROBIOLOGY OF DISEASE, 2007, 27 (01) :108-116
[6]   Cannabinoid CB2 receptors in human brain inflammation [J].
Benito, C. ;
Tolon, R. M. ;
Pazos, M. R. ;
Nunez, E. ;
Castillo, A. I. ;
Romero, J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) :277-285
[7]   The role of the endocannabinoid system in Alzheimer's disease: Facts and hypotheses [J].
Bisogno, Tiziana ;
Di Marzo, Vincenzo .
CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (23) :2299-2305
[8]  
Blurton-Jones Mathew, 2006, Current Alzheimer Research, V3, P437, DOI 10.2174/156720506779025242
[9]   The brain's default network - Anatomy, function, and relevance to disease [J].
Buckner, Randy L. ;
Andrews-Hanna, Jessica R. ;
Schacter, Daniel L. .
YEAR IN COGNITIVE NEUROSCIENCE 2008, 2008, 1124 :1-38
[10]   Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease [J].
Busche, Marc Aurel ;
Eichhoff, Gerhard ;
Adelsberger, Helmuth ;
Abramowski, Dorothee ;
Wiederhold, Karl-Heinz ;
Haass, Christian ;
Staufenbiel, Matthias ;
Konnerth, Arthur ;
Garaschuk, Olga .
SCIENCE, 2008, 321 (5896) :1686-1689
12345678